Assetmark Inc. reduced its stake in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report) by 2.0% during the 1st quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 623,015 shares of the exchange traded fund’s stock after selling 12,828 shares during the quarter. Assetmark Inc.’s holdings in SPDR S&P Biotech ETF were worth $79,578,000 as of its most recent filing with the SEC.
Several other hedge funds and other institutional investors have also recently bought and sold shares of XBI. Financial Life Planners purchased a new position in SPDR S&P Biotech ETF in the 1st quarter worth approximately $27,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC purchased a new stake in shares of SPDR S&P Biotech ETF during the fourth quarter valued at approximately $27,000. Intesa Sanpaolo Wealth Management purchased a new stake in shares of SPDR S&P Biotech ETF during the fourth quarter valued at approximately $30,000. SHP Wealth Management acquired a new position in shares of SPDR S&P Biotech ETF during the fourth quarter worth $31,000. Finally, Legacy Wealth Managment LLC ID acquired a new position in shares of SPDR S&P Biotech ETF during the fourth quarter worth $32,000.
SPDR S&P Biotech ETF Trading Down 2.7%
Shares of XBI stock opened at $152.00 on Friday. The company has a market capitalization of $10.34 billion, a PE ratio of 11.47 and a beta of 0.82. The firm has a fifty day simple moving average of $142.06 and a 200-day simple moving average of $132.23. SPDR S&P Biotech ETF has a twelve month low of $84.39 and a twelve month high of $165.71.
About SPDR S&P Biotech ETF
SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.
Featured Stories
- Five stocks we like better than SPDR S&P Biotech ETF
- Why Abbott Laboratories Stock Is Suddenly Winning Back Wall Street
- Revving Up Returns: Big Banks Race Through the Rate Plateau
- Why Uber’s Biggest Deal Yet Could Unlock Its Next Growth Phase
- Why Microsoft Is Playing a Different AI Game Than Big Tech—and Cash Flow Is the Test
Want to see what other hedge funds are holding XBI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report).
Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.
